Elliot Ehrich, SVP, R&D & CMO, Alkermes, Inc at Alkermes plc. (ALKS), sold 18,375 shares at $68.02 ($1.2M) on 2015-01-15, disclosed to the SEC on 2015-01-16.
Scheduled sale ($1.2M) by SVP, R&D & CMO, Alkermes, Inc under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.06 | 11,200 | $740K | 60.6% |
| 2 | $66.96 | 6,400 | $429K | 35.1% |
| 3 | $68.02 | 775 | $53K | 4.3% |
| Total | $66.46 avg | 18,375 | $1.2M | 100% |
| Filing → |
| ALKS | SELL | 2017-02-16 | $1.2M | — | Filing → |
| ALKS | SELL | 2017-01-18 | $1.3M | — | Filing → |
| ALKS | SELL | 2017-01-06 | $618K | — | Filing → |